Maat Pharma SA
PAR:MAAT
Income Statement
Earnings Waterfall
Maat Pharma SA
Revenue
|
2.6m
EUR
|
Cost of Revenue
|
-826k
EUR
|
Gross Profit
|
1.7m
EUR
|
Operating Expenses
|
-25.9m
EUR
|
Operating Income
|
-24.2m
EUR
|
Other Expenses
|
27k
EUR
|
Net Income
|
-24.1m
EUR
|
Income Statement
Maat Pharma SA
Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue |
1
N/A
|
1
+11%
|
1
+32%
|
2
+62%
|
2
-4%
|
3
+15%
|
|
Gross Profit | |||||||
Cost of Revenue |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
Gross Profit |
1
N/A
|
1
+5%
|
1
+29%
|
2
+62%
|
2
-6%
|
2
+5%
|
|
Operating Income | |||||||
Operating Expenses |
(10)
|
(13)
|
(15)
|
(16)
|
(22)
|
(26)
|
|
Selling, General & Administrative |
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
|
Research & Development |
(9)
|
(12)
|
(14)
|
(17)
|
(21)
|
(24)
|
|
Other Operating Expenses |
2
|
3
|
4
|
5
|
5
|
4
|
|
Operating Income |
(9)
N/A
|
(12)
-38%
|
(14)
-10%
|
(15)
-9%
|
(20)
-35%
|
(24)
-21%
|
|
Pre-Tax Income | |||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
|
Pre-Tax Income |
(9)
N/A
|
(12)
-37%
|
(14)
-11%
|
(15)
-7%
|
(20)
-34%
|
(24)
-22%
|
|
Net Income | |||||||
Income from Continuing Operations |
(9)
|
(12)
|
(14)
|
(15)
|
(20)
|
(24)
|
|
Net Income (Common) |
(9)
N/A
|
(12)
-37%
|
(14)
-11%
|
(15)
-7%
|
(20)
-34%
|
(24)
-22%
|
|
EPS (Diluted) |
-0.91
N/A
|
-1.24
-36%
|
-1.39
-12%
|
-1.32
+5%
|
-1.73
-31%
|
-1.97
-14%
|